[Featured Stock] Kolon TissueGene Delisted... Kolon Life Science and Group Stocks Down
[Asia Economy Reporter Minji Lee] Kolon TissueGene's delisting decision news is causing Kolon group companies to show weakness.
At 9:33 AM on the 5th in the KOSPI market, Kolon Life Science was traded at 28,800 KRW, down 11.8% from the previous close. This follows the Korea Exchange KOSDAQ Market Headquarters' decision to delist Kolon TissueGene the previous afternoon.
![[Image source=Yonhap News]](http://www.asiae.co.kr/news/img_view.htm?img=2019052813153449987_1559016934.jpg)
Additionally, Kolon was traded at 20,000 KRW, down 4.7% from the previous session, and Kolon Wo also fell by 7.8%.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "To Get Revenge on Ex-Girlfriend" US McDonald's Manager Spits on French Fries
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Kolon TissueGene's trading was suspended for 1 year and 5 months due to a change in the components of Invossa K Injection (Invossa), a gene therapy for osteoarthritis. Although Kolon TissueGene is reported to have filed an objection to prevent delisting, the damage to small shareholders who have been waiting for the resumption of trading is expected to be unavoidable.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
